Patients treated with first‐generation HCV protease inhibitors exhibit high ribavirin concentrations

Publisher： John Wiley & Sons Inc

E-ISSN： 1552-4604|55|5|517-524

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.5, 2015-05, pp. : 517-524

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dermatitis induced by first‐generation hepatitis C virus protease inhibitors

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 1, 2015-07 ,pp. : 311-312

John Wiley & Sons Inc

Access to resources Recommend Favorite

Direct costs of first‐generation protease inhibitors for the treatment of genotype 1 chronic hepatitis C viral infection

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 12, 2015-12 ,pp. : 974-976

John Wiley & Sons Inc

Access to resources Recommend Favorite

T‐cell homeostasis in chronic HCV‐infected patients treated with interferon and ribavirin or an interferon‐free regimen

By  

APMIS (ELECTRONIC), Vol. 903-4641, Iss. 10, 2015-10 ,pp. : 903-911

John Wiley & Sons Inc

Access to resources Recommend Favorite

T‐cell homeostasis in chronic HCV‐infected patients treated with interferon and ribavirin or an interferon‐free regimen

By  

APMIS (ELECTRONIC), Vol. 123, Iss. 10, 2015-10 ,pp. : 903-911

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety results of patients with HCV genotype 2 or 3 infection treated with ombitasvir/paritaprevir/ritonavir and sofosbuvir with or without ribavirin (QUARTZ II‐III)

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 25, Iss. 2, 2018-02 ,pp. : 118-125

John Wiley & Sons Inc

Access to resources Recommend Favorite